Drug makers Aurobindo Pharma, Glenmark and Zydus are recalling products in the US market due to manufacturing issues, according to the US health regulator. As per the latest Enforcement Report of ...

The tablets were shipped out across the U.S., though Aurobindo didn’t specify where the products were manufactured. Glenmark Pharmaceuticals, for its part, issued voluntary recalls for 90,528 ...

have injectable versions of their products in late-stage development. Specific terms of the deal haven’t been disclosed, but Glenmark has claimed rights to the drug in India, Asia Pacific ...

Glenmark’s current portfolio includes 201 products authorized for distribution in the US marketplace and 51 ANDA’s pending approval with the US FDA. In addition to these internal filings, Glenmark ...

Drug makers Aurobindo Pharma, Glenmark and Zydus are recalling products in the US market due to manufacturing issues, according to the US health regulator. As per the latest Enforcement Report of ...

Glenmark Pharmaceuticals reported a second-quarter profit on Thursday, helped by strong demand for its drugs that treat long-term illnesses. India's Glenmark Pharma posts Q2 profit on strong ...

Aurobindo Pharma, Glenmark recall products in US India is the largest supplier of generic medicines with around 20 per cent share in the global supply by manufacturing 60,000 different generic ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions.